Paul Lévesque
Chief Executive Officer chez THERATECHNOLOGIES INC.
Fortune : 120 848 $ au 31/03/2024
Profil
Paul Lévesque is currently the President, Chief Executive Officer & Director at Theratechnologies, Inc. He previously worked as the Global President-Rare Disease at Pfizer Inc. from 2018 to 2020.
Prior to that, he held the position of Vice President-France & Canada Marketing at PF Consumer Healthcare Canada ULC.
Mr. Lévesque completed his undergraduate degree at McGill University and Université Laval.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
THERATECHNOLOGIES INC.
0,16% | 21/01/2024 | 72 800 ( 0,16% ) | 120 848 $ | 31/03/2024 |
Postes actifs de Paul Lévesque
| Sociétés | Poste | Début |
|---|---|---|
| THERATECHNOLOGIES INC. | Chief Executive Officer | 06/04/2020 |
Anciens postes connus de Paul Lévesque
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 06/04/2020 |
PF Consumer Healthcare Canada ULC
 PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Chief Tech/Sci/R&D Officer | - |
Formation de Paul Lévesque
| Université Laval | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| THERATECHNOLOGIES INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
PF Consumer Healthcare Canada ULC
PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Health Technology |
